The U.S. dermatology market is expected to grow to $13.1 billion by 2017, representing a 5.3% CAGR. 34% of industry establishments are solo practices, while 48% include three or more physicians. The market includes anti-fungal, anti-infective, anti-inflammatory, and anti-pruritic medicines, as well as astringent medicines, medicines affecting skin differentiation, and scabicides/pediculicides. Major companies in the market are Bayer, Roche, Merck & Co., Galderma, Johnson & Johnson, AbbVie, GSK, Pfizer, and LEO. Common products are foaming cleansers and acne

1. by
Harishankar Sahu
MBA PM07
IIHMR University, Jaipur

2.  The $10.1 billion U.S. dermatology market is
expected to grow to $13.1 billion by 2017,
representing 5. 3 % CAGR.
 34% of industry establishments are solo
practices.
 48% of industry practices include three or
more physicians.

4.  Anti-fungal Medicines
 Anti-infective Medicines
 Anti-inflammatory and Anti-pruritic
Medicines
 Astringent Medicines
 Medicines affecting skin differentiation
 Scabicides and Pediculicides

5.  Bayer
 Roche
 Merck & Co.
 Galderma
 Johnson & Jhonson
 AbbVie
 GSK
 Pfizer
 LEO

6. PRODUCTS
Foaming Cleanser

7. Acne Treatment